Press Release - Panacea Biotec Limited completes transfer of its Pharmaceuticals Business to its wholly owned subsidiary Panacea Biotec Pharma Limited
Panacea Biotec Ltd. is pleased to announce that the company has completed transfer of its Pharmaceuticals Business by way of slump sale (as a going concern) to its wholly-owned subsidiary viz. Panacea Biotec Pharma Limited (PBPL) with an objective to streamline operations and create inherent focus among the businesses of the Company.
PBPL obtained the drug manufacturing license on 01.02.2020. Pursuant to above and in compliance with the terms and conditions of the BTA the transfer of the Companys pharmaceuticals business to PBPL by way of slump sale as a going concern has become effective from 01.02.2020. The documents relating to closing of transaction as above were executed on 04.02.2020.
A copy of the Press Release being issued to the media etc. in this regard is enclosed for your kind reference and record please.
Panacea Biotec: Announcement under Regulation 30 (LODR)-Press Release / Media Release
February 5, 2020
Download PDF
Panacea Biotec